This week’s reported global health innovation funding included:

Angle Health, a San Francisco, CA-based AI-native healthcare benefits platform, raised $600M (consisting of a $200M Series C and a $400M tender offer) led by Vitruvian Partners, with participation from Town Hall Ventures, Blumberg Capital, Portage Ventures, PruVen Capital, and Y Combinator. <source>

Heidi, a Melbourne, VIC, Australia-based AI care partner for clinicians, raised $340M, consisting of a $100M Series C led by Blackbird, with participation from Phoenix Court, Point72 Private Investments, and Headline, plus a $240M growth investment led by General Catalyst's Customer Value Fund. <source>

Anew Labs, a Shanghai, China-based AI drug discovery company spun off from ByteDance, raised $290M led by HSG, IDG Capital, and Hillhouse Investment, with participation from 5Y Capital, Gaorong Ventures, Primavera Venture Partners, Boyu Capital, the Shanghai Future Industries Fund, and SBP Group. <source>

Thatch, a San Francisco, CA-based health benefits platform, raised $108M from existing investors The General Partnership, Index Ventures, General Catalyst, and Andreessen Horowitz. <source>

Penelope Health, a New York, NY-based real-time provider and payer policy intelligence platform, raised $100M led by Thoreau, with participation from existing backers Bertelsmann Healthcare Investments, Twine Ventures, and Seedcamp. <source>

Altis Labs, a Toronto, Canada-based AI endpoint company accelerating oncology clinical trials, raised $25M co-led by OrbiMed and Qiming Venture Partners USA, with participation from Innovation Endeavors, Benchstrength, Fusion Fund, and Lumira Ventures via the Cancer Breakthrough Fund. <source>

Corridor, a New York, NY-based AI health benefits brokerage for small businesses, raised $25M led by Bain Capital Ventures, with participation from BoxGroup and executives from OpenAI, Scale AI, and Ramp. <source>

Teal Health, a San Francisco, CA-based creator of an FDA-authorized at-home HPV cervical cancer screening device, raised $22M led by .406 Ventures, with participation from Emerson Collective, Forerunner, Serena Ventures, and MPower Partners. <source>

Mithrl, a San Francisco, CA-based AI infrastructure company for biopharma R&D, raised $20M led by Obvious Ventures, with participation from Headline, AGI House, and pharma executives. <source>

Ayble Health, a Boston, MA-based AI-enabled virtual multidisciplinary GI and autoimmune clinic, raised $16M led by Neon, with participation from Unum Ventures, Upfront Ventures, M13, Cleveland Clinic Ventures, DigiTx, and Accomplice. <source>

ImpriMed, a Palo Alto, CA-based AI-driven precision cancer medicine company, raised $10M led by LB Investment, with participation from NAVER D2SF, Samsung Securities, Alois Ventures, BonAngels, and Han River Partners. <source>

MozartAI, a Medellín, Colombia-based healthtech automation platform expanding into Mexico, raised $10M from undisclosed investors. <source>

Prosper Health, a Weston, FL-based virtual therapy provider for autistic and neurodivergent adults, raised $10M from six accredited investors, including Maverick Ventures. <source>

Ferry Health, a San Francisco, CA-based agentic AI platform that automates healthcare scheduling for patients, raised $9M co-led by Andreessen Horowitz and Index Ventures, with participation from Avid Ventures, Layout Ventures, SV Angel, BoxGroup, Asymmetric Capital Partners, and angel investors. <source>

Disha, a Gurugram, India-based AI-powered health coaching platform, raised $5.96M led by General Catalyst, with participation from Elevation Capital and Flamel Performing Creatives. <source>

Axo Longevity, a London, UK- and Madrid, Spain-based preventive health membership platform, raised $5M from MS&AD Ventures, Izou Partners, LifeX Ventures, Everywhere Ventures, UNQ, 51 Ventures, Cistern Capital, and NIAN Sports & Entertainment. <source>

Kairon Health, a New York, NY-based AI execution layer for value-based care organizations, raised $5M led by Flare Capital Partners, with participation from Tau Ventures, Lightbank, General Advance, and Pave Health Ventures. <source>

Health Force, a Barcelona, Spain-based developer of AI agents for hospital operations, raised €4.2M (~$4.8M) led by LUMO Labs, with participation from Step Venture, Next Tier Ventures, Target Global, and Calm/Storm. <source>

Medcast, a Bowral, NSW, Australia-based clinical education and AI knowledge platform, raised A$5.4M (~$3.5M) led by Best Practice Software. <source>

Blair Health, a Toronto, ON, Canada-based virtual specialist care provider for women's health and menopause, raised C$4.24M (~$3M) co-led by BDC's Thrive Venture Fund, Accelia Capital, and Ogaei Investments, with participation from Ontario Centre of Innovation and angel investors. <source>

Medow Health, a Sydney, NSW, Australia-based AI co-pilot for specialist physicians and surgeons, raised A$3.5M (~$2.5M) from existing investors. <source>

ReFresh, a Sydney, NSW, Australia-based workplace psychosocial safety platform, raised A$2.5M (~$1.8M) led by Black Nova Venture Capital, with participation from Antler and Archangel Ventures. <source>

IMS Solutions, a Solihull, England, UK-based diagnostics spin-out developing steroid hormone tests, raised £1.1M (~$1.47M) led by Midlands Mindforge, with participation from SFC Capital, UKI2S, NG Bio, British Business Bank, and private investors. <source>

Anees Health, a Cairo, Egypt-based integrated care platform for older adults and chronic condition management, raised an undisclosed amount in seed funding. <source>

MediPro Direct, an Alpine, UT-based nationwide mobile diagnostics provider, received an undisclosed strategic investment from CGF Holdings. <source>

H Clinical, a St. Petersburg, FL-based clinical research operating platform serving Latin America, received an undisclosed majority investment from Emerald Square Ventures. <source>

Physioplus Healthcare, a Jaipur, India-based digital physiotherapy platform, received an undisclosed strategic seed investment from HBF India. <source>

Respiree, a Houston, TX-based AI platform for monitoring disease progression, expanded its Series A syndicate with new investors ARKRAY & PARTNERS Pte. Ltd. and Bizedge Capital, joining existing lead investors We Venture Capital and ClavystBio for an undisclosed amount. <source>

Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox. Follow us on LinkedIn for daily updates on Health Moonshots.